Annual accounts receivable:
$50.00M+$22.58M(+82.34%)Summary
- As of today (May 29, 2025), ADMA annual accounts receivable is $50.00 million, with the most recent change of +$22.58 million (+82.34%) on December 31, 2024.
- During the last 3 years, ADMA annual accounts receivable has risen by +$21.42 million (+74.96%).
- ADMA annual accounts receivable is now at all-time high.
Performance
ADMA Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$99.41M+$49.41M(+98.83%)Summary
- As of today (May 29, 2025), ADMA quarterly accounts receivable is $99.41 million, with the most recent change of +$49.41 million (+98.83%) on March 31, 2025.
- Over the past year, ADMA quarterly accounts receivable has increased by +$49.79 million (+100.34%).
- ADMA quarterly accounts receivable is now at all-time high.
Performance
ADMA Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ADMA Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +82.3% | +100.3% |
| 3 y3 years | +75.0% | +287.9% |
| 5 y5 years | +1340.9% | +1298.6% |
ADMA Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +222.5% | at high | +541.2% |
| 5 y | 5-year | at high | +1340.9% | at high | +1469.4% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
ADMA Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $99.41M(+98.8%) |
| Dec 2024 | $50.00M(+82.3%) | $50.00M(-0.3%) |
| Sep 2024 | - | $50.14M(+66.5%) |
| Jun 2024 | - | $30.11M(-39.3%) |
| Mar 2024 | - | $49.62M(+81.0%) |
| Dec 2023 | $27.42M(+76.9%) | $27.42M(-12.4%) |
| Sep 2023 | - | $31.32M(-14.7%) |
| Jun 2023 | - | $36.73M(+38.5%) |
| Mar 2023 | - | $26.52M(+71.0%) |
| Dec 2022 | $15.51M(-45.7%) | $15.51M(-25.8%) |
| Sep 2022 | - | $20.90M(+10.7%) |
| Jun 2022 | - | $18.88M(-26.3%) |
| Mar 2022 | - | $25.63M(-10.3%) |
| Dec 2021 | $28.58M(+115.9%) | $28.58M(+40.1%) |
| Sep 2021 | - | $20.39M(-13.4%) |
| Jun 2021 | - | $23.54M(+53.3%) |
| Mar 2021 | - | $15.36M(+16.1%) |
| Dec 2020 | $13.24M(+281.5%) | $13.24M(+109.0%) |
| Sep 2020 | - | $6.33M(-2.8%) |
| Jun 2020 | - | $6.51M(-8.4%) |
| Mar 2020 | - | $7.11M(+104.8%) |
| Dec 2019 | $3.47M(+149.2%) | $3.47M(-52.6%) |
| Sep 2019 | - | $7.32M(+43.8%) |
| Jun 2019 | - | $5.09M(+288.2%) |
| Mar 2019 | - | $1.31M(-5.9%) |
| Dec 2018 | $1.39M | $1.39M(-66.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $4.13M(+8.7%) |
| Jun 2018 | - | $3.80M(+3.8%) |
| Mar 2018 | - | $3.66M(-5.7%) |
| Dec 2017 | $3.88M(+281.2%) | $3.88M(+158.7%) |
| Sep 2017 | - | $1.50M(-34.6%) |
| Jun 2017 | - | $2.29M(+172.9%) |
| Mar 2017 | - | $839.90K(-17.5%) |
| Dec 2016 | $1.02M(+10.1%) | $1.02M(-23.3%) |
| Sep 2016 | - | $1.33M(+60.6%) |
| Jun 2016 | - | $826.70K(-12.4%) |
| Mar 2016 | - | $943.90K(+2.1%) |
| Dec 2015 | $924.50K(+140.8%) | $924.50K(-23.0%) |
| Sep 2015 | - | $1.20M(+129.8%) |
| Jun 2015 | - | $522.50K(+48.7%) |
| Mar 2015 | - | $351.40K(-8.5%) |
| Dec 2014 | $384.00K(>+9900.0%) | $384.00K(-31.7%) |
| Sep 2014 | - | $562.20K(-30.0%) |
| Jun 2014 | - | $803.50K(+65.9%) |
| Mar 2014 | - | $484.40K(>+9900.0%) |
| Dec 2013 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2013 | - | $335.10K(+41.5%) |
| Jun 2013 | - | $236.90K(-27.4%) |
| Mar 2013 | - | $326.30K(+734.5%) |
| Dec 2012 | $39.10K | $39.10K(-36.8%) |
| Sep 2012 | - | $61.90K(-71.9%) |
| Jun 2012 | - | $220.10K |
FAQ
- What is ADMA Biologics annual accounts receivable?
- What is the all time high annual accounts receivable for ADMA Biologics?
- What is ADMA Biologics annual accounts receivable year-on-year change?
- What is ADMA Biologics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for ADMA Biologics?
- What is ADMA Biologics quarterly accounts receivable year-on-year change?
What is ADMA Biologics annual accounts receivable?
The current annual accounts receivable of ADMA is $50.00M
What is the all time high annual accounts receivable for ADMA Biologics?
ADMA Biologics all-time high annual accounts receivable is $50.00M
What is ADMA Biologics annual accounts receivable year-on-year change?
Over the past year, ADMA annual accounts receivable has changed by +$22.58M (+82.34%)
What is ADMA Biologics quarterly accounts receivable?
The current quarterly accounts receivable of ADMA is $99.41M
What is the all time high quarterly accounts receivable for ADMA Biologics?
ADMA Biologics all-time high quarterly accounts receivable is $99.41M
What is ADMA Biologics quarterly accounts receivable year-on-year change?
Over the past year, ADMA quarterly accounts receivable has changed by +$49.79M (+100.34%)